Navigation Links
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
Date:9/22/2007

National Cervical Cancer Coalition unites women in joining the fight for education and early detection and prevention of the Human Papillomavirus

(HPV) and cervical cancer

WASHINGTON, Sept. 21 /PRNewswire-USNewswire/ -- More than 80 women and men gathered at the Hyatt Regency Capitol Hill in the heart of Washington, D.C. to attend the First Annual Cervical Cancer/HPV Conference, conducted by the National Cervical Cancer Coalition (NCCC). During the two-day conference, controversial issues such as nationally mandating the cervical cancer vaccine for young women were tackled, as well as the discussion of debunking the stigma associated with HPV, a Sexually Transmitted Infection (STI). The conference marks the first time women with HPV and cervical cancer gathered together in the United States to discuss the disease, treatments and prevention.

Perhaps one of the most important prevention topics discussed during the conference was presented by Juan C. Felix, M.D., professor of pathology and obstetrics and gynecology, Keck School of Medicine of the University of Southern California, in regards to the new HPV vaccines. When attendees were asked during the beginning of the conference whether or not they would support a national mandate for all girls entering middle school to get the HPV vaccine, a little more than 42 percent could agree. After listening to Dr. Felix, and receiving all the facts and information, the NCCC took a second vote using a real-time computerized voting system and discovered more than 70 percent now advocated mandating the vaccine for girls between the ages of 9 and 13, as long as there was an "opt-out" offered to parents with objections. Of course, the attendees stressed that getting screened and having their routine PAP test, when coupled with an HPV test, is still the most effective early detection method available to women.

Additional HPV facts presented during the conference came from Heidi Ba
'/>"/>

SOURCE National Cervical Cancer Coalition
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/ -- BioTrends Research Group, Inc. releas... report, the first in a multi-phase syndicated mar...or Ortho-Biotech,s Stelara, from product launch th...wave of the report provides quantitative informati...nformation from a subset of 20. The reports asses...
(Date:11/25/2009)...v. 25 Regado Biosciences, a privat...rombotic aptamers with active control agents, anno...ll be presenting at the Piper Jaffray 21st Annual ...l in New York City. Dr. Mazzo,s presentation will...nd will include an overview of the Company,s pipel...
(Date:11/25/2009)... Nov. 25 Swissray International, I...graphy ( ddR ) systems, announced today that its o...vestor with a long term view towards growing Swiss...ded all assets and intellectual property, as well ...ess and growth Swissray is now poised to move to t...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Cardiac Science Announces Third Quarter Results 6112 1Cardiac Science Announces Third Quarter Results 6112 2Cardiac Science Announces Third Quarter Results 6112 3Cardiac Science Announces Third Quarter Results 6112 4Cardiac Science Announces Third Quarter Results 6112 5Cardiac Science Announces Third Quarter Results 6112 6Cardiac Science Announces Third Quarter Results 6112 7Cardiac Science Announces Third Quarter Results 6112 8Cardiac Science Announces Third Quarter Results 6112 9Cardiac Science Announces Third Quarter Results 6112 10Cardiac Science Announces Third Quarter Results 6112 11Cardiac Science Announces Third Quarter Results 6112 12Cardiac Science Announces Third Quarter Results 6112 13Cardiac Science Announces Third Quarter Results 6112 14Cardiac Science Announces Third Quarter Results 6112 15Cardiac Science Announces Third Quarter Results 6112 16Cardiac Science Announces Third Quarter Results 6112 17Cardiac Science Announces Third Quarter Results 6112 18Cardiac Science Announces Third Quarter Results 6112 19Cardiac Science Announces Third Quarter Results 6112 20Forecast Looks Good for India Pharma Shows 6107 1Forecast Looks Good for India Pharma Shows 6107 2Forecast Looks Good for India Pharma Shows 6107 3Stipkala LLC to Sponsor Texas Life Science Conference November 12 13 2009 6102 1
...E PARK, N.C.--(BUSINESS WIRE)--Apr 3, 2007 -,Icage...ing a,planned meeting of the independent Data Moni...rial of senicapoc (formerly,ICA-17043) for the tre...ecommended that the trial be terminated because of...risis rate, the primary,endpoint. In making their ...
..., 2007--Treatment data from,Synovate Healthcare&rs...10,000 breast cancer patients in the UK could beco...lower death rates in,patients. The treatment was t...e edition of The Lancet (12 February 2007). Lower,...tched to the,aromotase inhibitor, Aromasin (exemes...
Other Medicine Technology:Icagen Terminates Phase III ASSERT Study 2Icagen Terminates Phase III ASSERT Study 3Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 2Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 3
(Date:11/27/2009)...v. 27 Team Garmin-Slipstream, the ... to ethical sporting and developing the next gener...t will become Team Garmin-Transitions with the add...he team. Transitions Optical is the world,s leadin...ost advanced photochromic technology in the widest...
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...de; announced today that Spectrum Health (Grand Ra...ise orthopedic templating solution and its TraumaC... (PRWEB) November 27, 2009 -- Voyant Health&t...Rapids, Michigan) has licensed its TraumaCad Enter...aCad Extend workflow solution, to allow its orthop...
(Date:11/27/2009)...tive anatomy education apps from Modality and Lipp...es learning opportunities for iPhone and iPod touc...vember 27, 2009 -- Modality, Inc. and Lippincott...rs Kluwer Health, today announced the availability...ore. Clemente’s Anatomy, Rohen’s Photo...
(Date:11/26/2009)...cans living with diabetes will nearly double, incr...n 2034. Over the same period, spending on diabetes...336 billion, even with no increase in the prevalen... of Chicago report in the December issue of Diabe...overed by Medicare will rise from 8.2 million to 1...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ielman, M.D, Duke University Medical Center to sho...ting HIV infections than those which charge a smal...he testing center and is therefore a very efficien...the testing centre were 4 per day but after the fr...
... Internet and e-mail contribute towards strengthen...is has been revealed by the Pew Internet and Ameri...social relations get affected as a result of the I... in those networks do not live close to them, a Pe...
...ndian Government to produce some films with the Na...ht the achievements of Indian Scientists, //in add... in science. The name of the new initiative of the... The films will focus on nano-technology, the s...
...icist at the Max-Planck Institute for Dynamics and...which helped the researchers to understand the spr...s with the help of money trials.// He tracked...scientist fight against easily transmissible disea...
... common cancer next to breast cancer in women and ...y recognisation of cervical cancer would help in e...tality due to cervical cancer. A cytologic screeni...above the age of 18 years require yearly Pap smear...
...tion (APA) has released tips to help prevent the b...ion during the National Heart Month.// Research ha...ess will have an adverse impact on their health an... in effective ways that don't at the same time tak...
Other Medicine News:Health News:Free HIV Tests Brings Crowd to the Testing Centers 2Health News:Tracking the spread of disease with the help of money 2
...c diagnostic instrument that measures the refracti...e using a Hartmann-Shack wavefront sensor. The mea...-cylindrical) refractive errors and irregularities...on in the human eye. The WaveScan software uses th...
Zywave® II
ZYMAR™ 2.5 mL
REFRESH P.M.®
Medicine Products: